Massive congratulations to Professor Gordon Smith, Professor Steve Charnock-Jones and Dr Paul Kirk who have been selected for funding by the Wellcome Leap In Utero programme: measurement and modelling during gestational development. Their application to use proteomics to better predict pregnancy complications leading to stillbirth was successful along with 12 other performers.
“Every 16 seconds one baby is stillborn.
Wellcome Leap’s $50M In Utero program aims to create the scalable capacity to measure, model and predict gestational development with a primary goal to reduce stillbirth rates by half.”
For further details about the programme visit Wellcome Leap